Liangxing Wu

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pyrido[3,2-d]pyrimidine compounds as immunomodulators
- Patent number 12,247,038
- Issue date Mar 11, 2025
- Incyte Corporation
- Jingwei Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 12,247,026
- Issue date Mar 11, 2025
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 12,187,743
- Issue date Jan 7, 2025
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic urea compounds as JAK2 V617F inhibitors
- Patent number 12,187,725
- Issue date Jan 7, 2025
- Incyte Corporation
- Yanran Ai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaryl amide compounds as sting activators
- Patent number 12,129,267
- Issue date Oct 29, 2024
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...
- Patent number 12,060,433
- Issue date Aug 13, 2024
- Incyte Corporation
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyridazine and imidazopyridine compounds and uses thereof
- Patent number 12,030,889
- Issue date Jul 9, 2024
- Incyte Corporation
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,999,740
- Issue date Jun 4, 2024
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic pyrazolyl amines as CDK2 inhibitors
- Patent number 11,981,671
- Issue date May 14, 2024
- Incyte Corporation
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spirocyclic lactams as JAK2 V617F inhibitors
- Patent number 11,958,861
- Issue date Apr 16, 2024
- Incyte Corporation
- Stacey Shepard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylamide compounds as CDK2 inhibitors
- Patent number 11,919,904
- Issue date Mar 5, 2024
- Incyte Corporation
- Alexander Sokolsky
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibi...
- Patent number 11,919,908
- Issue date Mar 5, 2024
- Incyte Corporation
- Andrew W. Buesking
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic heteroaryl compounds as sting activators
- Patent number 11,912,722
- Issue date Feb 27, 2024
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyrimidine derivatives as A2A/A2B inhibitors
- Patent number 11,873,304
- Issue date Jan 16, 2024
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,873,309
- Issue date Jan 16, 2024
- Incyte Corporation
- Kaijiong Xiao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
- Patent number 11,866,432
- Issue date Jan 9, 2024
- Incyte Corporation
- Alexander Sokolsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,866,435
- Issue date Jan 9, 2024
- Incyte Corporation
- Neil Lajkiewicz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic amines as CDK2 inhibitors
- Patent number 11,851,426
- Issue date Dec 26, 2023
- Incyte Corporation
- Yingda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted tricyclic compounds as FGFR inhibitors
- Patent number 11,840,534
- Issue date Dec 12, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridazine compounds and uses thereof
- Patent number 11,840,546
- Issue date Dec 12, 2023
- Incyte Corporation
- Jun Pan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,787,793
- Issue date Oct 17, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic urea compounds as JAK2 V617F inhibitors
- Patent number 11,780,840
- Issue date Oct 10, 2023
- Incyte Corporation
- Yanran Ai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic pyridone compounds as JAK2 V617F inhibitors
- Patent number 11,767,323
- Issue date Sep 26, 2023
- Incyte Corporation
- Kai Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F i...
- Patent number 11,753,413
- Issue date Sep 12, 2023
- Incyte Corporation
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,718,605
- Issue date Aug 8, 2023
- Incyte Corporation
- Zhiyong Yu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic heterocyclic compounds as sting activators
- Patent number 11,713,317
- Issue date Aug 1, 2023
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Naphthyridinone compounds as JAK2 V617F inhibitors
- Patent number 11,691,971
- Issue date Jul 4, 2023
- Incyte Corporation
- Stacey Shepard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as immunomodulators
- Patent number 11,673,883
- Issue date Jun 13, 2023
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic heterocycles as FGFR4 inhibitors
- Patent number 11,667,635
- Issue date Jun 6, 2023
- Incyte Corporation
- Liang Lu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20250084104
- Publication date Mar 13, 2025
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...
- Publication number 20250059293
- Publication date Feb 20, 2025
- INCYTE CORPORATION
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
- Publication number 20250041310
- Publication date Feb 6, 2025
- INCYTE CORPORATION
- Hui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20240360140
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20240309008
- Publication date Sep 19, 2024
- INCYTE CORPORATION
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
- Publication number 20240246974
- Publication date Jul 25, 2024
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC AMINES AS CDK2 INHIBITORS
- Publication number 20240174664
- Publication date May 30, 2024
- INCYTE CORPORATION
- Yingda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS
- Publication number 20240150354
- Publication date May 9, 2024
- INCYTE CORPORATION
- Yanran Ai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINE COMPOUNDS AND USES THEREOF
- Publication number 20240083918
- Publication date Mar 14, 2024
- INCYTE CORPORATION
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-L1/STING CONJUGATES AND METHODS OF USE
- Publication number 20230398225
- Publication date Dec 14, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20230357255
- Publication date Nov 9, 2023
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230226062
- Publication date Jul 20, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20230192696
- Publication date Jun 22, 2023
- INCYTE CORPORATION
- Le Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230192689
- Publication date Jun 22, 2023
- INCYTE CORPORATION
- Zhenwu Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230146129
- Publication date May 11, 2023
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20230100875
- Publication date Mar 30, 2023
- INCYTE CORPORATION
- Neil Lajkiewicz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS
- Publication number 20230024173
- Publication date Jan 26, 2023
- INCYTE CORPORATION
- Qinda Ye
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BICYCLIC PYRAZOLYL AMINES AS CDK2 INHIBITORS
- Publication number 20230002376
- Publication date Jan 5, 2023
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220348594
- Publication date Nov 3, 2022
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLYL BICYCLIC AMINES AS CDK2 INHIBITORS
- Publication number 20220340579
- Publication date Oct 27, 2022
- INCYTE CORPORATION
- Joshua Hummel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220340600
- Publication date Oct 27, 2022
- INCYTE CORPORATION
- Jingwei Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
- Publication number 20220315595
- Publication date Oct 6, 2022
- INCYTE CORPORATION
- Jun Pan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIROCYCLIC LACTAMS AS JAK2 V617F INHIBITORS
- Publication number 20220281887
- Publication date Sep 8, 2022
- INCYTE CORPORATION
- Stacey Shepard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIB...
- Publication number 20220233529
- Publication date Jul 28, 2022
- INCYTE CORPORATION
- Hui Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEAZAGUAINE COMPOUNDS AS JAK2 V617F INHIBITORS
- Publication number 20220213108
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Andrew W. Buesking
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220213090
- Publication date Jul 7, 2022
- INCYTE CORPORATION
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220194931
- Publication date Jun 23, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS
- Publication number 20220169649
- Publication date Jun 2, 2022
- INCYTE CORPORATION
- Yanran Ai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20220135570
- Publication date May 5, 2022
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
- Publication number 20220089588
- Publication date Mar 24, 2022
- INCYTE CORPORATION
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY

Liangxing Wu

Person

Patents Grantslast 30 patents

Pyrido[3,2-d]pyrimidine compounds as immunomodulators

Heterocyclic compounds as immunomodulators

Heterocyclic compounds as immunomodulators

Tricyclic urea compounds as JAK2 V617F inhibitors

Heteroaryl amide compounds as sting activators

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...

Imidazopyridazine and imidazopyridine compounds and uses thereof

Fused pyrazine derivatives as A2A / A2B inhibitors

Bicyclic pyrazolyl amines as CDK2 inhibitors

Spirocyclic lactams as JAK2 V617F inhibitors

Sulfonylamide compounds as CDK2 inhibitors

Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibi...

Tricyclic heteroaryl compounds as sting activators

Fused pyrimidine derivatives as A2A/A2B inhibitors

Heterocyclic compounds as immunomodulators

Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors

Heterocyclic compounds as immunomodulators

Bicyclic amines as CDK2 inhibitors

Substituted tricyclic compounds as FGFR inhibitors

Imidazopyridazine compounds and uses thereof

Heterocyclic compounds as immunomodulators

Tricyclic urea compounds as JAK2 V617F inhibitors

Tricyclic pyridone compounds as JAK2 V617F inhibitors

Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F i...

Heterocyclic compounds as immunomodulators

Tricyclic heterocyclic compounds as sting activators

Naphthyridinone compounds as JAK2 V617F inhibitors

Heterocyclic compounds as immunomodulators

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Bicyclic heterocycles as FGFR4 inhibitors

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...

Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

BICYCLIC AMINES AS CDK2 INHIBITORS

TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS

IMIDAZOPYRIDAZINE COMPOUNDS AND USES THEREOF

PD-L1/STING CONJUGATES AND METHODS OF USE

IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

SPIRO COMPOUNDS AS INHIBITORS OF KRAS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

IMIDAZOLYL PYRIMIDINYLAMINE COMPOUNDS AS CDK2 INHIBITORS

BICYCLIC PYRAZOLYL AMINES AS CDK2 INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

PYRAZOLYL BICYCLIC AMINES AS CDK2 INHIBITORS

PYRIDO[3,2-D]PYRIMIDINE COMPOUNDS AS IMMUNOMODULATORS

IMIDAZOPYRIDAZINE AND IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF

SPIROCYCLIC LACTAMS AS JAK2 V617F INHIBITORS

COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIB...

DEAZAGUAINE COMPOUNDS AS JAK2 V617F INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

TRICYCLIC UREA COMPOUNDS AS JAK2 V617F INHIBITORS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS